There was a strong trend for an increase in CD4+ thymocytes in the SLE mice that received the leptin antagonist (Figure 4G), so it may be that positive selection of DP thymocytes into a CD4+ or CD8+ thymocytes is impacted in some way. The gene discussed is LEP; the disease is systemic lupus erythematosus.